Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers

Cutaneous adverse reaction (CARs) from mRNA-based COVID-19 vaccines have been reported in the literature.[1, 2] On the contrary, information regarding Sinovac (CoronaVac), (SV) inactivated virus and adenoviral vector AstraZeneca (ChAdOx1 nCoV-19), (AZ) vaccines remains scarce. We have conducted this...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2022-03, Vol.36 (3), p.e158-e161
Main Authors: Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., Kumtornrut, C., Kerr, S.J., Asawanonda, P., Jantarabenjakul, W., Klaewsongkram, J.
Format: Article
Language:English
Subjects:
COVID-19
COVID-19 Vaccines
Covid‐19 Special Forum
Health Personnel
Humans
Letter to the Editor
Prospective Studies
SARS-CoV-2
Vaccination - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cutaneous adverse reaction (CARs) from mRNA-based COVID-19 vaccines have been reported in the literature.[1, 2] On the contrary, information regarding Sinovac (CoronaVac), (SV) inactivated virus and adenoviral vector AstraZeneca (ChAdOx1 nCoV-19), (AZ) vaccines remains scarce. We have conducted this prospective cohort study to address this issue.
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.17761